Inspec

Inspec Net Margin

The Net Profit Margin of Inspec (6656.T) as of Oct 22, 2026 is 3.10 %. In the previous year, Net Profit Margin was -6.36 % — a change of -148.76% (higher).

Net Margin

3.10 %

YoY

-148.76%

Last updated:

Net Profit Margin of Inspec is 2026 3.10 % . Net Profit Margin of Inspec was 2025 -6.36 % . It decreases by -148.76% higher compared to the previous year.

Inspec's net margin stands at 3.1%, down from 8.8% several years earlier.

The Inspec Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
7.80 JPY
Jan 1, 2020
9.22 JPY
Jan 1, 2021
-93.89 JPY
Jan 1, 2022
8.82 JPY
Jan 1, 2023
3.44 JPY
Jan 1, 2024
-21.21 JPY
Jan 1, 2025
-6.36 JPY
Jan 1, 2026
3.10 JPY
The Inspec Net Margin history
YEARNet MarginYoY
3.10 %-148.76%
-6.36 %-70.02%
-21.21 %-716.10%
3.44 %-60.96%
8.82 %-109.39%
-93.89 %-1,118.70%
9.22 %+18.20%
7.80 %-132.33%
-24.12 %-589.92%
4.92 %-417.61%
-1.55 %-126.66%
5.81 %+98.52%
2.93 %-451.92%
-0.83 %+225.17%
-0.26 %-572.45%
0.05 %-111.94%
-0.45 %-74.03%
-1.75 %+1,071.80%
-0.15 %-785.87%
0.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Net Profit Margin of Inspec is 3.10 % in 2026.

Net Profit Margin of Inspec changed from -6.36 % to 3.10 %, representing a -148.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Inspec since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Inspec with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Inspec

All Key Metrics — Inspec